NameEligibleStudy sitesMore information
ABC008Adults with inclusion body myositis (IBM)35 sites in US    12 sites abroadMore details;
Abcuro/Syneos
617-865-5079
NCT05721573
Brepocitinib (VALOR)Adults with dermatomyositis (DM)>30 sites in US 
>50 sites abroad
More details;
Proivant
212-634-9743
NCT05437263
CABA-201 (CAR T cell therapy)Adults with DM, ASyS, NMUC Irvine, CA
Additional sites expected soon
More details;
Cabaletta Bio
NCT06154252
Daxdilimab
Adults with DM or ASyS13 sites in US
32 sites abroad
More details; Horizon Therapeutics
866-479-6742
NCT05669014
Dazukibart
PF-06823859
Adults with active DM or PM18 sites in USMore details;
Pfizer
800-718-1021
NCT05895786
Efgartigimod (ALKIVIA)

Adults with IIM

10 sites in US
8 sites abroad
More details;
argenx
857-350-4834
NCT05523167
Enpatoran (NEPTUNIA)Adults with DM or PM9 sites in US
12 sites abroad
More details;
EMD Serono
888-275-7376
NCT05650567
GLPG3667Adults with dermatomyositis (DM)4 sites in USMore details;
Galapagos NV
321-534-2900
NCT05695950
IgPro20 (Hizentra)Adults with active dermatomyositis (DM)76 sites worldwideMore details;
CSL Behring
610-878-4000
NCT04044690
Nintedanib
(MINT)
Adults with ILD and myositis14 sites in USMore details
MINTcc@pitt.edu
412-648-9989
NCT05799755
Nipocalimab (SPIREA)Adults with IIM27 sites worldwideMore details;
J&J Innovative Medicine
844-434-4210
NCT05379634
RavulizumabAdults with dermatomyositis (DM)10 sites in US
29 sites abroad
More details;
Alexion
855-752-2356
NCT04999020
SirolimusAdults with inclusion body myositis (IBM)2 sites in US
7 sites in Australia
More details;
913-945-9926
NCT04789070